Trials / Unknown
UnknownNCT00394628
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
A Phase 1b/2a, Multicenter, Open-Label Study of AQ4N in Combination With Radiation Therapy and Temozolomide, to Evaluate the Safety, Tolerability, and Efficacy in Subjects With Newly Diagnosed Glioblastoma Multiforme
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Novacea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase 1b of the study, will evaluate the safety and tolerability of AQ4N treatment at three different dose levels. Phase 2a of the study, will further evaluate the safety, tolerability, and in addition efficacy of AQ4N treatment at a tolerated dose selected from Phase 1b.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AQ4N | |
| DRUG | Temozolomide | |
| PROCEDURE | Radiotherapy |
Timeline
- Start date
- 2006-10-01
- First posted
- 2006-11-01
- Last updated
- 2007-05-30
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00394628. Inclusion in this directory is not an endorsement.